VarCov Co’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$559K Sell
19,329
-1,045
-5% -$25.7K 0.27% 131
2026
Q2
$437K Buy
+20,374
New +$312K 0.17% 206

Other funds holding ADPT

VarCov Co's ADPT Position: Q3 2026 in Review

VarCov Co reduced its Adaptive Biotechnologies (ADPT) stake by 5.1% in Q3 2026, selling an estimated $25.7K and leaving 19,329 shares worth $559K. The position accounts for 0.27% of the portfolio, ranked #131.

VarCov Co first reported a position in ADPT in Q2 2026 and has held it in 2 quarters since. 334 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.

  • VarCov Co held 19,329 shares of Adaptive Biotechnologies worth $559K as of Q3 2026.
  • VarCov Co sold 1,045 Adaptive Biotechnologies shares in Q3 2026, an estimated $25.7K.
  • Adaptive Biotechnologies made up 0.27% of VarCov Co's portfolio in Q3 2026, its #131 holding.
  • VarCov Co first reported a position in Adaptive Biotechnologies in Q2 2026 and has held it in 2 quarters since.
  • 334 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.

Based on VarCov Co's 13F filing for Q3 2026, filed 16 Nov 2026.